Stock data

中裕 (4147)

中裕 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$53.87M, down 9.1% from a year earlier. EPS over the last four quarters totals -NT$0.51.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 中裕 in Insightr